1. Home
  2. NXE vs MMSI Comparison

NXE vs MMSI Comparison

Compare NXE & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXE
  • MMSI
  • Stock Information
  • Founded
  • NXE 2011
  • MMSI 1987
  • Country
  • NXE Canada
  • MMSI United States
  • Employees
  • NXE N/A
  • MMSI N/A
  • Industry
  • NXE
  • MMSI Medical/Dental Instruments
  • Sector
  • NXE
  • MMSI Health Care
  • Exchange
  • NXE Nasdaq
  • MMSI Nasdaq
  • Market Cap
  • NXE 5.6B
  • MMSI 4.8B
  • IPO Year
  • NXE N/A
  • MMSI 1990
  • Fundamental
  • Price
  • NXE $9.12
  • MMSI $87.31
  • Analyst Decision
  • NXE
  • MMSI Strong Buy
  • Analyst Count
  • NXE 0
  • MMSI 8
  • Target Price
  • NXE N/A
  • MMSI $107.38
  • AVG Volume (30 Days)
  • NXE 12.0M
  • MMSI 517.1K
  • Earning Date
  • NXE 11-05-2025
  • MMSI 10-30-2025
  • Dividend Yield
  • NXE N/A
  • MMSI N/A
  • EPS Growth
  • NXE N/A
  • MMSI N/A
  • EPS
  • NXE N/A
  • MMSI 1.95
  • Revenue
  • NXE N/A
  • MMSI $1,477,128,000.00
  • Revenue This Year
  • NXE N/A
  • MMSI $12.79
  • Revenue Next Year
  • NXE N/A
  • MMSI $6.41
  • P/E Ratio
  • NXE N/A
  • MMSI $44.74
  • Revenue Growth
  • NXE N/A
  • MMSI 11.41
  • 52 Week Low
  • NXE $3.91
  • MMSI $78.12
  • 52 Week High
  • NXE $9.95
  • MMSI $111.45
  • Technical
  • Relative Strength Index (RSI)
  • NXE 52.89
  • MMSI 62.14
  • Support Level
  • NXE $8.27
  • MMSI $80.93
  • Resistance Level
  • NXE $9.95
  • MMSI $89.29
  • Average True Range (ATR)
  • NXE 0.53
  • MMSI 2.06
  • MACD
  • NXE 0.05
  • MMSI 0.66
  • Stochastic Oscillator
  • NXE 58.04
  • MMSI 78.35

About NXE Nexgen Energy Ltd.

NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: